CELLEN LIFE SCIENCES LIMITED

Dissolved London

Manufacture of basic pharmaceutical products

1 employees website.com
Manufacture of basic pharmaceutical productsManufacture of pharmaceutical preparations +2
C

CELLEN LIFE SCIENCES LIMITED

Manufacture of basic pharmaceutical products

Founded 19 Aug 2019 Dissolved London, United Kingdom 1 employees website.com
Manufacture of basic pharmaceutical productsManufacture of pharmaceutical preparationsWholesale of pharmaceutical goodsSpecialists medical practice activities
Accounts Due 31 May 2025 12 months overdue
Confirmation
Net assets £3M £3M 2023 year on year
Total assets £4M £2M 2023 year on year
Total Liabilities £865K £280K 2023 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

7th Floor 21 Lombard Street London EC3V 9AH

Full company profile for CELLEN LIFE SCIENCES LIMITED (12164338), a dissolved company based in London, United Kingdom. Incorporated 19 Aug 2019. Manufacture of basic pharmaceutical products. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type Total Exemption Full
Next accounts 31 December 2024
Due by 30 September 2025 9 months

Net Assets, Total Assets & Total Liabilities (2020–2023)

Cash in Bank

£760.00

Increased by £678.00 (+827%)

Net Assets

£3.13M

Increased by £2.54M (+433%)

Total Liabilities

£864.78k

Decreased by £279.54k (-24%)

Turnover

N/A

Employees

1

Decreased by 3 (-75%)

Debt Ratio

22%

Decreased by 44 (-67%)

Financial History

Revenue, profit, EBITDA and key financial figures

2023
Dec Year End
2022
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

3 Allotments 112,246 Shares £640k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
4 Feb 20208,845£390k£44.09
28 Jan 20203,402£150k£44.09
27 Aug 201999,999£100k£1

Officers

Officers

2 active 1 resigned
Status
Bhaskar, Arun Kumar, DrDirectorBritishEngland5628 Dec 2022Active
Rogers, John DalrympleDirectorAmericanFrance6628 Oct 2022Active

Shareholders

Shareholders (34)

The Cellen Employee Benefit Trust
13.8%
30,000
4420 Global Ventures Llc - Twinfocus
11.8%
25,623

Persons with Significant Control

Persons with Significant Control (0)

0 Active 2 Ceased

Eric Gustaf Bystrom

Ceased 24 Aug 2019

Ceased

Benjamin Marie Viaris De Lesegno

Ceased 24 Oct 2019

Ceased

Group Structure

Group Structure

CELLEN LIFE SCIENCES LIMITED Current Company
REALISATION I 2024 LTD united kingdom
REALISATION B 2024 LTD united kingdom

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
13 Mar 2026InsolvencyLiquidation In Administration Move To Dissolution
11 Sept 2025InsolvencyLiquidation In Administration Extension Of Period
12 Apr 2025InsolvencyLiquidation In Administration Progress Report
15 Nov 2024InsolvencyLiquidation In Administration Statement Of Affairs With Form Attached
7 Oct 2024InsolvencyLiquidation Administration Notice Deemed Approval Of Proposals
13 Mar 2026 Insolvency

Liquidation In Administration Move To Dissolution

11 Sept 2025 Insolvency

Liquidation In Administration Extension Of Period

12 Apr 2025 Insolvency

Liquidation In Administration Progress Report

15 Nov 2024 Insolvency

Liquidation In Administration Statement Of Affairs With Form Attached

7 Oct 2024 Insolvency

Liquidation Administration Notice Deemed Approval Of Proposals

Recent Activity

Latest Activity

Liquidation In Administration Move To Dissolution

1 months ago on 13 Mar 2026

Liquidation In Administration Extension Of Period

7 months ago on 11 Sept 2025

Liquidation In Administration Progress Report

1 years ago on 12 Apr 2025

Liquidation In Administration Statement Of Affairs With Form Attached

1 years ago on 15 Nov 2024

Liquidation Administration Notice Deemed Approval Of Proposals

1 years ago on 7 Oct 2024